Study links COPD drugs to higher cardiovascular risks

05/30/2013 | AAFP News Now

Cardiovascular risks are higher for older patients who begin long-acting beta agonists and long-acting anticholinergics to treat chronic obstructive pulmonary disease, Canadian researchers reported in JAMA Internal Medicine. Prescott Woodruff, M.D., of the University of California, San Francisco, wrote in a commentary that while the drugs are mainstays of COPD treatment, the safety issues brought up by the study put the medications in a gray area.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ